Effective at the market close on Friday September 25, 2020, PRNB will be removed from the LifeSci Biotechnology Clinical Trials Index and its value will be redistributed to the remaining index components based on their weights.
On August 17, 2020, Principia Biopharma agreed to be acquired by Sanofi for $100.00 per share in cash.
